World News Insights
1-3 Minute Gist

All Topics Group

Pharmaceutical company and industry lobbying in the U.S. Congress

06/25/2008

The influence on legislation and federal regulation that the pharmaceutical companies and industry associations are seeking, with $168 million spent on lobbying in 2006. As a result pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.

Grouped Articles

Drug Industry Boosts Lobbying

Wall Street Journal 06.25.2008

Health-Care Firms Have Supported Lawmakers Debating Reform

Washington Post 07.21.2009

Dana Milbank - Washington Sketch: GOP's Steele Couldn't Have Said It Better Himself

Washington Post 07.21.2009

Obama's Health Expert Gets Political

Wall Street Journal 07.24.2009

The Lobbying Web

New York Times 08.02.2009

As Congress Goes on Break, Health Lobbying Heats Up

Wall Street Journal 08.05.2009

‘Blue Dogs’ or Corporate Shills?

Wall Street Journal 08.05.2009

Lobbyists Fight Last Big Plans to Cut Health Care Costs

New York Times 10.11.2009

In House, Many Spoke With One Voice: Lobbyists’

New York Times 11.15.2009

William Daley Brings Management Experience as Chief of Staff

New York Times 01.06.2011

India and America, Two Peas in a Pod

New York Times 11.08.2011

Why an MRI costs $1,080 in America and $280 in France - The Washington Post

Washington Post 03.05.2012

Obamacare: The reckoning - The Washington Post

Washington Post 03.23.2012

White House visitor logs show lobbying going strong - The Washington Post

Washington Post 05.21.2012

E-Mails Highlight Extent of Obama's Deal With Industry on Health Care

New York Times 06.08.2012

Emails Reveal How the White House Bought Big Pharma

Wall Street Journal 06.12.2012

ObamaCare's Secret History

Wall Street Journal 06.11.2012

Biotech Firms, Billions at Risk, Lobby States to Limit Generics

New York Times 01.28.2013

Why an MRI costs $1,080 in America and $280 in France | Wonkblog

Washington Post 03.15.2013

One Industry’s Hold on the Senate

New York Times 04.01.2013

Mylan Reacts to EpiPen Backlash

WSJ 08.26.2016


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us